Filamin C in cardiomyopathy: from physiological roles to DNA variants

Shen Song1, Anteng Shi1, Hong Lian1

  • 1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

Heart Failure Reviews
|September 18, 2021
PubMed

Insights

Mutations in the Filamin C (FLNC) gene are linked to various cardiomyopathies. Understanding FLNC

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathy is a leading cause of death, with familial cases often linked to genetic mutations.
  • Filamin C (FLNC) is crucial for sarcomere stability and its mutations are implicated in myofibrillar myopathy and cardiomyopathy.
  • Recent findings highlight FLNC mutations as critical in cardiomyopathy pathogenesis.

Purpose of the Study:

  • To review the physiological roles of Filamin C in cardiomyocytes.
  • To summarize genetic evidence linking FLNC mutations to cardiomyopathies.
  • To elucidate pathomechanisms in FLNC-related cardiomyopathy.

Main Methods:

  • Literature review of studies on FLNC gene and cardiomyopathy.
  • Analysis of FLNC protein variants (truncated vs. non-truncated) in different cardiomyopathy types.
  • Summary of described pathomechanisms including protein aggregation and haploinsufficiency.

Main Results:

  • Truncated FLNC is associated with dilated and arrhythmogenic right ventricular cardiomyopathy.
  • Non-truncated FLNC is linked to hypertrophic and restrictive cardiomyopathy.
  • Two key pathomechanisms identified: protein aggregation and haploinsufficiency.

Conclusions:

  • FLNC mutations are a significant genetic cause of various cardiomyopathies.
  • Different FLNC mutation types correlate with specific cardiomyopathy subtypes.
  • Understanding FLNC biology is vital for developing targeted therapies for FLNC-related cardiomyopathies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
96
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.5K
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
5.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
127
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
117